Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines

Acta Neuropathologica

Volumn 95, Issue 3, 1998, Pages 287-290

  Husain, Nuzhat ^a   Chiocca, E Antonio ^a   Rainov, Nikolai ^b   Louis, David N ^a   Zervas, Nicholas T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; ASTROCYTOMA; BLOTTING, WESTERN; FAS LIGAND PROTEIN; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MEMBRANE GLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0031910060     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050799     Document Type: Article

References (11)

1. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377:630-632
2. French LE, Hahne M, Viard I, Radlgniber G, Zanone R, Becker K, Muller C, Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immunepriviliged tissues and co-expression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335-343
3. Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, Tachibana O, Kleihues P, Ohgaki H (1997) Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol 7:863-869
4. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192
5. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand P, Fontana A, Lienard D, Cerottini JC, Tschopp J (1996) Melanoma cell expression of Fas (Apo-l/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366
6. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3:738-743
7. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652
8. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
9. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99:1173-1178
10. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligandexpressing tumor cells - A mechanism of immune evasion? Nat Med 2:1361-1366
11. Tachibana O, Lampe J, Kleihues P, Ohgaki H (1996) Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathol 92:431-434